Publications Library

Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy

Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and -3 Polyunsaturated Fatty Acids

Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.

An orthotopic mouse model of laryngeal squamous cell carcinoma

Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma

Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.

Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors

Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects

Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis.